Loading
Yanuki
ARTICLE DETAIL
Safran Offers Concessions to UK Regulator Over Collins Aerospace Deal Concerns | Novo Nordisk and Hims & Hers Settle Patent Dispute, Collaborate on Weight Loss Medications | Oil Price Volatility Amidst Iran War | Writers Guild Prioritizes Health Plan, AI, and Compensation in Negotiations | Live Nation and Justice Department Reach Settlement in Antitrust Case | Walmart vs BJ’s Wholesale: Which Retailer Is the Better Buy? | Byron Allen Acquires Stake in Starz: What It Means for the Media Landscape | Exxon Mobil Stock Soars on Swiss Exchange Amid Record Volume | Stock Market Plunge: Sensex Tumbles as Oil Surges Amid Iran War Fears | Safran Offers Concessions to UK Regulator Over Collins Aerospace Deal Concerns | Novo Nordisk and Hims & Hers Settle Patent Dispute, Collaborate on Weight Loss Medications | Oil Price Volatility Amidst Iran War | Writers Guild Prioritizes Health Plan, AI, and Compensation in Negotiations | Live Nation and Justice Department Reach Settlement in Antitrust Case | Walmart vs BJ’s Wholesale: Which Retailer Is the Better Buy? | Byron Allen Acquires Stake in Starz: What It Means for the Media Landscape | Exxon Mobil Stock Soars on Swiss Exchange Amid Record Volume | Stock Market Plunge: Sensex Tumbles as Oil Surges Amid Iran War Fears

Business / Mergers And Acquisitions

Safran Offers Concessions to UK Regulator Over Collins Aerospace Deal Concerns

French aerospace supplier Safran appears closer to securing regulatory approval for its acquisition of parts of Collins Aerospace, following concessions offered to the UK's Competition and Markets Authority (CMA). However, the company's sto...

Share
X LinkedIn

Safran Offers Concessions to UK Regulator Over Collins Aerospace Deal Concerns

Key Insights

  • **Concessions Offered:** Safran proposed selling the majority of Collins Aerospace's 'Trimmable Horizontal Stabilizer Actuator Systems' (THSA) business to address competition concerns.
  • **CMA Reaction:** The UK regulator indicated that these proposed divestments *could* resolve its concerns, pending further feedback from third parties. An in-depth investigation was previously announced.
  • **EU Approval Pending:** Separately, the European Commission is reportedly close to granting conditional approval for the $1.8 billion deal, contingent on Safran divesting certain electromechanical activities in North America.
  • **Stock Market Reaction:** Despite progress on the regulatory front, Safran's shares fell on the Euronext Paris, dropping around 2.6% to €227.10 (and potentially further according to other reports) following the news.
  • **Why this matters:** This deal impacts the highly concentrated aerospace supply chain. Regulatory scrutiny in major markets like the UK and EU is critical for such large transactions to proceed, ensuring fair competition.

In-Depth Analysis

Safran's proposed $1.8 billion acquisition of Collins Aerospace's flight control business faced hurdles from the UK's Competition and Markets Authority (CMA) due to concerns it could lessen competition. The specific components in question, Trimmable Horizontal Stabilizer Actuator Systems (THSA), are crucial for controlling the horizontal stabilizer (tailplane) movement in commercial aircraft and are manufactured by Collins in the UK.

To alleviate these concerns, Safran has formally offered to divest the bulk of this THSA business. The CMA has responded cautiously positively, stating these commitments *might* be sufficient. The regulator is now opening a consultation period, inviting feedback from industry stakeholders before making a final decision. If satisfied after the consultation, the CMA intends to approve the deal without proceeding to a more detailed Phase 2 investigation.

Parallel regulatory processes are underway in the EU, where the European Commission is also expected to grant approval soon, reportedly conditional on Safran selling its North American electromechanical business unit. This indicates Safran is making significant structural changes to satisfy regulators on both sides of the channel.

Interestingly, Safran's stock price reacted negatively to the news, declining significantly on the day. This could reflect broader market jitters, perhaps linked to recent US tariff announcements impacting the aerospace sector (as noted by analysts), or specific investor concerns about the cost or complexity of the required divestments, despite the deal moving closer to approval.

Read source article

FAQ

- **Q: What specific business did Safran offer to sell?

**

- **Q: Why were regulators concerned about the Safran-Collins deal?

**

- **Q: Has the deal been fully approved now?

**

Takeaways

  • Large international acquisitions, especially in sensitive sectors like aerospace, often face significant regulatory scrutiny and require concessions.
  • Divestments (selling parts of a business) are a common tool used to address anti-competition concerns raised by regulators.
  • Market reactions (like stock price changes) don't always align perfectly with seemingly positive news steps; broader factors or specific deal complexities can influence investor sentiment.
  • Keep an eye on final decisions from the CMA and the European Commission regarding this deal.

Discussion

Do you think Safran's concessions are sufficient to ensure fair competition? Let us know!

*Share this article with others who need to stay ahead of this trend!*

Sources

Source 1: Safran-Angebot könnte CMA-Bedenken gegen Collins-Deal ausräumen (finanzen.net) target="_blank" Source 2: Investoren meiden heute den Anteilsschein von Safran SA (ARIVA.DE) target="_blank" Source 3: EU bereitet sich auf die Genehmigung des Angebots von Safran an die amerikanische Collins vor (MarketScreener) target="_blank"

Disclaimer

This article was compiled by Yanuki using publicly available data and trending information. The content may summarize or reference third-party sources that have not been independently verified. While we aim to provide timely and accurate insights, the information presented may be incomplete or outdated.

All content is provided for general informational purposes only and does not constitute financial, legal, or professional advice. Yanuki makes no representations or warranties regarding the reliability or completeness of the information.

This article may include links to external sources for further context. These links are provided for convenience only and do not imply endorsement.

Always do your own research (DYOR) before making any decisions based on the information presented.